The number of physicians trained to perform surgical oncology research is inadequate when considering that most patients with solid tumors undergo surgery as part of their clinical management. Improving the care of these patients is in the interests of the NCI. It is critical that more surgeons are involved in patient-oriented research and that other physicians be trained in oncology research related to the surgical management of cancer patients. The three objectives of this application are 1) To increase the number of well-trained surgeons and affiliated physicians who perform patient-oriented cancer research, 2) To enhance the depth of research training of surgeons by offering advanced degrees during their research training, and 3) To increase the number of minority and female surgeons in the academic practice of surgical oncology. Trainees will be enrolled in one of three research tracks: Translational Laboratory Science (TLS), Health Services and Outcomes research (HSO), and Oncology Clinical Trials (OCT). These tracks will be structured and will include associated curriculum, and appropriate mentors. However, there will be flexibility to include training in othe research areas and in other research-related skills, which will augment the trainees' educational experiences. Surgical residents with a minimum of two years of clinical training will be admitted to the program, and other non-surgical, yet oncologically related MD/DO trainees may be admitted, but will fill no more than 25% of the trainee positions. There will be a total of six trainees at any given time. Trainees will enter a dedicated, 2-3 year training period that will include a core research project related to solid tumor oncology, plus coursework selected to match their research track, with the option for a Master's degree or PhD. Strong emphasis will be placed on learning skills required for survival in research careers combined with academic clinical practice. These will include research ethics, grant writing, research design, data analysis, budgeting, manuscript writing, and stress management. By this approach, a cohort of young, well-trained surgeons and associated physicians will be developed who will have the tools to perform high quality, ethical, translational and clinical research specifically centered o human tumor oncology.
Only a small number of surgeons perform research aimed at improving outcomes of cancer patients by safely introducing scientific breakthroughs to their care and management. We propose to train young surgeons and associated physicians, including those from traditionally under-represented minorities, to perform this research throughout their careers and to increase the survival and quality of life of patients suffering fro cancer.
Martin, Allison N; Narayanan, Sowmya; Turrentine, Florence E et al. (2018) Clinical Factors and Postoperative Impact of Bile Leak After Liver Resection. J Gastrointest Surg 22:661-667 |
Knisely, Anne T; Michaels, Alex D; Mehaffey, J Hunter et al. (2018) Race is associated with completion of neoadjuvant chemotherapy for breast cancer. Surgery 164:195-200 |
Hassinger, Taryn E; Mehaffey, J Hunter; Johnston, Lily E et al. (2018) Roux-en-Y gastric bypass is safe in elderly patients: a propensity-score matched analysis. Surg Obes Relat Dis 14:1133-1138 |
Hassinger, Taryn E; Turrentine, Florence E; Thiele, Robert H et al. (2018) Acute Kidney Injury in the Age of Enhanced Recovery Protocols. Dis Colon Rectum 61:946-954 |
Obeid, Joseph M; Kunk, Paul R; Zaydfudim, Victor M et al. (2018) Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time? Cancer Immunol Immunother 67:161-174 |
Goudreau, Bernadette J; Hassinger, Taryn E; Hedrick, Traci L et al. (2018) Academic or community practice? What is driving decision-making and career choices. Surgery 164:571-576 |
Young, Andrew M; Hassinger, Taryn E; Contrella, Benjamin N et al. (2018) Colo-Urethral Fistula: an Uncommon Complication of Sigmoid Diverticulitis. J Gastrointest Surg 22:1641-1642 |
Michaels, Alex D; Newhook, Timothy E; Adair, Sara J et al. (2018) CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer. Clin Cancer Res 24:1415-1425 |
Stine, Jonathan G; Wang, Jennifer; Shah, Puja M et al. (2018) Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study. Liver Int 38:94-101 |
Martin, Allison N; Silverstein, Allison; Ssebuufu, Robinson et al. (2018) Impact of delayed care on surgical management of patients with gastric cancer in a low-resource setting. J Surg Oncol 118:1237-1242 |
Showing the most recent 10 out of 67 publications